Eugen Feist

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 23

Top Topics

Rheumatoid Arthritis

Disease Activity

Monoclonal Antibody

Top Venues

Journal of clinical medicine

Rheumatology and therapy

Annals of the rheumatic diseases

The Journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Anja Plenske, Pascal Klaus, Thomas Meng
Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE. Rheumatology and therapy 11 (2) (2024)
Roberto Caporali, Dennis G McGonagle, Viviam Canon Garcia, Hilde Rabijns, Katrin Toennessen, Mary Elizabeth Chappell, Mary Edwards, Paul Miller, Neil Hansell, Joe W E Moss, Sara Graziadio, Eugen Feist
Systematic Review and Metaanalysis of Pharmacological Interventions in Adult-Onset Still Disease and the Role of Biologic Disease-Modifying Antirheumatic Drugs. The Journal of rheumatology 51 (5) (2024)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Anja Plenske, Pascal Klaus, Thomas Meng
Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE. Rheumatology and therapy 11 (2) (2024)
Roberto Caporali, Dennis G McGonagle, Viviam Canon Garcia, Hilde Rabijns, Katrin Toennessen, Mary Elizabeth Chappell, Mary Edwards, Paul Miller, Neil Hansell, Joe W E Moss, Sara Graziadio, Eugen Feist
Systematic Review and Metaanalysis of Pharmacological Interventions in Adult-Onset Still Disease and the Role of Biologic Disease-Modifying Antirheumatic Drugs. The Journal of rheumatology 51 (5) (2024)
Eugen Feist, Roy M Fleischmann, Saeed Fatenejad, Daria Bukhanova, Sergey Grishin, Sofia Kuzkina, Michael Luggen, Evgeniy Nasonov, Mikhail Samsonov, Josef S Smolen
Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment. Annals of the rheumatic diseases (2024)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Anja Plenske, Pascal Klaus, Thomas Meng
Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE. Rheumatology and therapy (2024)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Anja Plenske, Pascal Klaus, Thomas Meng
Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE. Rheumatology and therapy 11 (2) (2024)
Aiden Haghikia, Tobias Hegelmaier, Denise Wolleschak, Martin Böttcher, Vaia Pappa, Jeremias Motte, Dominic Borie, Ralf Gold, Eugen Feist, Larissa Valor-Méndez, Dimitrios Mougiakakos
Clinical efficacy and autoantibody seroconversion with CD19-CAR T cell therapy in a patient with rheumatoid arthritis and coexisting myasthenia gravis. Annals of the rheumatic diseases (2024)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Thilo Klopsch, Anja Plenske, Lisa K Blindzellner, Pascal Klaus, Thomas Meng, Peter-Andreas Löschmann
Correction: Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes. Rheumatology and therapy (2023)
Sarah Ohrndorf, Martin Krusche, Xenofon Baraliakos, Eugen Feist, Barbara Gundelach, Isabell Haase, Bimba Franziska Hoyer, Uta Kiltz, Michaela Köhm, Anna Julia Voormann, Philipp Sewerin, Johanna Mucke, null null
'Status Quo' on Different Aspects of Gender Distribution in Rheumatology in Germany-Results from a Nationwide Online Survey among Physicians. Journal of clinical medicine 12 (13) (2023)
Michaela Köhm, Ann Christina Foldenauer, Tanja Rossmanith, Rieke Alten, Martin Aringer, Marina Backhaus, Gerd R Burmester, Eugen Feist, Herbert Kellner, Klaus Krueger, Ulf Müller-Ladner, Andrea Rubbert-Roth, Hans-Peter Tony, Siegfried Wassenberg, Harald Burkhardt, Frank Behrens
Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA). Journal of clinical medicine 11 (24) (2022)
Stylianos Tomaras, Gernot Keyßer, Eugen Feist
Curcumin: Useful add-on for Rheumatic Diseases? Journal of clinical medicine 11 (10) (2022)
Michaela Köhm, Ann Christina Foldenauer, Tanja Rossmanith, Rieke Alten, Martin Aringer, Marina Backhaus, Gerd R Burmester, Eugen Feist, Herbert Kellner, Klaus Krueger, Ulf Müller-Ladner, Andrea Rubbert-Roth, Hans-Peter Tony, Siegfried Wassenberg, Harald Burkhardt, Frank Behrens
Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA). Journal of clinical medicine 11 (24) (2022)
Joerg Christoph Henes, Sebastian Jonas Saur, David M Kofler, Claudia Kedor, Christoph Meisner, Marion Schuett, Krusche Martin, Ina Koetter, Theodoros Xenitidis, Hendrik Schulze-Koops, Eugen Feist, null null
Tocilizumab for the Treatment of Familial Mediterranean Fever-A Randomized, Double-Blind, Placebo-Controlled Phase II Study. Journal of clinical medicine 11 (18) (2022)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Thilo Klopsch, Anja Plenske, Lisa K Blindzellner, Pascal Klaus, Thomas Meng, Peter-Andreas Löschmann
Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes. Rheumatology and therapy 9 (2) (2022)
Michaela Köhm, Ann Christina Foldenauer, Tanja Rossmanith, Rieke Alten, Martin Aringer, Marina Backhaus, Gerd R Burmester, Eugen Feist, Herbert Kellner, Klaus Krueger, Ulf Müller-Ladner, Andrea Rubbert-Roth, Hans-Peter Tony, Siegfried Wassenberg, Harald Burkhardt, Frank Behrens
Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA). Journal of clinical medicine 11 (24) (2022)
Marc Pawlitzki, Christopher Nelke, Leoni Rolfes, Rebecca Hasseli, Stylianos Tomaras, Eugen Feist, Anne Schänzer, Saskia Räuber, Liesa Regner, Corinna Preuße, Yves Allenbach, Olivier Benveniste, Heinz Wiendl, Werner Stenzel, Sven G Meuth, Tobias Ruck
NK Cell Patterns in Idiopathic Inflammatory Myopathies with Pulmonary Affection. Cells 10 (10) (2021)
Evgeniy Nasonov, Saeed Fatenejad, Eugen Feist, Mariana G Ivanova, Elena Korneva, Diana G Krechikova, Aleksey L Maslyanskiy, Mikhail Samsonov, Rumen Malinov Stoilov, Elena V Zonova, Mark C Genovese
Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study. Annals of the rheumatic diseases (2021)
Eugen Feist
Autoinflammation It Is! Journal of clinical medicine 10 (21) (2021)
Khetam Ghannam, Jan Zernicke, Claudia Kedor, Joachim Listing, Gerd-R Burmester, Dirk Foell, Eugen Feist
Distinct Effects of Interleukin-1β Inhibition upon Cytokine Profile in Patients with Adult-Onset Still's Disease and Active Articular Manifestation Responding to Canakinumab. Journal of clinical medicine 10 (19) (2021)
Stylianos Tomaras, Carl Christoph Goetzke, Tilmann Kallinich, Eugen Feist
Adult-Onset Still's Disease: Clinical Aspects and Therapeutic Approach. Journal of clinical medicine 10 (4) (2021)
Annika Reddig, Linda Voss, Karina Guttek, Dirk Roggenbuck, Eugen Feist, Dirk Reinhold
Impact of Different JAK Inhibitors and Methotrexate on Lymphocyte Proliferation and DNA Damage. Journal of clinical medicine 10 (7) (2021)
Goitybell Martínez, Eugen Feist, Maité Martiatu, Hilda Elisa Garay, Bárbara Torres
Autoantibodies against a novel citrullinated fibrinogen peptide related to smoking status, disease activity and therapeutic response to methotrexate in cuban patients with early rheumatoid arthritis. Rheumatology international 40 (11) (2020)